RA
MDCO

Royce & Associates’s Medicines Co MDCO Stock Holding History

Royce & Associates’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-27,432
Closed -$1.04M – 1273
2017
Q2 		$1.04M Hold
27,432
– – 0.01% 965
2017
Q1 		$1.34M Sell
27,432
-17,800
-39% -$812K 0.01% 937
2016
Q4 		$1.53M Hold
45,232
– – 0.01% 873
2016
Q3 		$1.71M Sell
45,232
-5,000
-10% -$188K 0.01% 841
2016
Q2 		$1.69M Hold
50,232
– – 0.01% 837
2016
Q1 		$1.6M Sell
50,232
-58,000
-54% -$1.89M 0.01% 863
2015
Q4 		$4.04M Sell
108,232
-29,700
-22% -$1.12M 0.02% 683
2015
Q3 		$5.24M Sell
137,932
-65,000
-32% -$2.28M 0.03% 633
2015
Q2 		$5.81M Sell
202,932
-1,878,438
-90% -$52.3M 0.02% 698
2015
Q1 		$58.3M Sell
2,081,370
-2,566,370
-55% -$72.1M 0.22% 117
2014
Q4 		$129M Sell
4,647,740
-2,081,435
-31% -$51.6M 0.45% 43
2014
Q3 		$150M Buy
6,729,175
+73,150
+1% +$1.86M 0.51% 36
2014
Q2 		$193M Buy
6,656,025
+540,825
+9% +$14.4M 0.58% 25
2014
Q1 		$174M Buy
6,115,200
+1,515,358
+33% +$50.1M 0.51% 30
2013
Q4 		$178M Sell
4,599,842
-237,303
-5% -$8.49M 0.51% 30
2013
Q3 		$162M Buy
4,837,145
+784,480
+19% +$25M 0.48% 32
2013
Q2 		$125M Buy
+4,052,665
New +$136M 0.39% 57

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates's MDCO Position: Q3 2017 in Review

Royce & Associates sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 27,432 shares — an estimated $1.04M sold.

Royce & Associates first reported a position in MDCO in Q2 2013 and held it in 17 quarters. The position peaked at $193M in Q2 2014. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Royce & Associates reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Royce & Associates sold 27,432 Medicines Co shares in Q3 2017, an estimated $1.04M.
  • Royce & Associates first reported a position in Medicines Co in Q2 2013 and held it in 17 quarters.
  • Royce & Associates's Medicines Co position peaked at $193M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Royce & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.